ICER Outlines Planned Review for Beta Thalassemia Treatments
The Institute for Clinical and Economic Review (ICER) on Monday released a new document outlining a planned review of LentiGlobin [...]
ICER Plans Review of Gene Therapy for Hemophilia A
The Institute for Clinical and Economic Review (ICER) announced plans to review BioMarin Pharmaceutical's gene therapy for hemophilia A, valoctocogene [...]
Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint
Swarali Tadwalkar, MPHIntern Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the [...]
Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.
Swarali Tadwalker, MPH Hardly a day goes by without a new article being published in the mainstream press [...]